Ag-Clopidogrel 75 mg (Clopidogrel (Clopidogrel Bisulfate) TABLET) 75 MG

AG-CLOPIDOGREL 75 MG is a blood thinner tablet used to prevent blood clots. This medication is commonly prescribed for cardiovascular health and is manufactured by Angita Pharma Inc. in Canada.

Strength

75 MG

Pack Size

30/100/500

Manufacturer / TM Owner

ANGITA PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AG-CLOPIDOGREL 75 MG is primarily used to reduce the risk of heart attack or stroke in people who have conditions like coronary artery disease or peripheral vascular disease. It works by preventing blood clots from forming in the body. This medication is often used in combination with aspirin for better results. People often ask, 'What is AG-CLOPIDOGREL used for?' It is typically prescribed for long-term use to maintain cardiovascular health.

Side Effects

Common effects of AG-CLOPIDOGREL 75 MG may include bleeding or bruising more easily than usual. Some people might experience stomach pain, indigestion, or diarrhea. It is important to monitor for any unusual bleeding or signs of infection while taking this medication.

Precautions & Warnings

AG-CLOPIDOGREL 75 MG should be handled with care, especially if you have a history of bleeding disorders or are planning surgery. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Store this medication at room temperature, away from moisture and heat.

Avoid Interactions

AG-CLOPIDOGREL 75 MG may interact with other blood thinners, NSAIDs, and certain antidepressants. Alcohol consumption should be limited as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

AG-CLOPIDOGREL is used to prevent blood clots in people with cardiovascular conditions, reducing the risk of heart attack or stroke.

AG-CLOPIDOGREL 75 MG is typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include bleeding or bruising more easily, stomach pain, and diarrhea.

It is advisable to limit alcohol consumption while taking AG-CLOPIDOGREL, as it can increase the risk of bleeding.

Store AG-CLOPIDOGREL tablets at room temperature, away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.